First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)
Clinical trial NCT07216066 · RECRUITING
Trial details
- NCT number
- NCT07216066
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-05
- Primary completion
- 2029-06-07
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.